/5
0 avis
OS-097 Effect of rifaximin in severe cirrhotic patients with ascites: a double-blind randomized placebo-controlled phase 3 trial
Archive ouverte
Meeting abstract de l'European Association for the Study of the Liver Congress (EASL 2024), June 05-08 2024, Milan (Italy). International audience
Consulter en ligne
Chargement des enrichissements...